Sarah Guégan

Performance of the SCORTEN During the First Five Days of Hospitalization to Predict the Prognosis of Epidermal Necrolysis

Sarah Guégan, Sylvie Bastuji‐Garin, E. Poszepczynska-Guigné et al. · Journal of Investigative Dermatology · 2005 · 244 citations · Full text

First Five Days, Surgical Pathology, Prognosis +5

Phase II Study of Pembrolizumab As First-Line, Single-Drug Therapy for Patients With Unresectable Cutaneous Squamous Cell Carcinomas

E. Maubec, Marouane Boubaya, Peter Petrow et al. · Journal of Clinical Oncology · 2020 · 168 citations

NRAS Mutation Is the Sole Recurrent Somatic Mutation in Large Congenital Melanocytic Nevi

C. Charbel, R Fontaine, Gabriel G. Malouf et al. · Journal of Investigative Dermatology · 2013 · 161 citations · Full text

Nras Mutation, Somatic Variant, Genetic Disorder +3

Characterization of Endogenous Human Promyelocytic Leukemia Isoforms

Wilfried Condemine, Yuki Takahashi, Jun Zhu et al. · Cancer Research · 2006 · 150 citations · Full text

Natural history of fetal cell microchimerism during and following murine pregnancy

Kiarash Khosrotehrani, Kirby L. Johnson, Sarah Guégan et al. · Journal of Reproductive Immunology · 2005 · 129 citations

Developmental Biology, Natural History, Fetal Medicine +9